# Why that word, real?

> About Real TRT — Real TRT is an editorial project examining published kisspeptin research, with particular interest in testosterone responses and what happens afterward.

**About Real TRT**

I want the interesting result to survive the next question.

## Real

Real is a demanding word. It can sound reassuring before anyone has said what the reassurance rests on. With Real TRT, I wanted to follow the testosterone question far enough for that word to become awkward: a measurable response, a different population, a later observation, an outcome someone actually values.

Kisspeptin gives the question somewhere concrete to go. The [early study in healthy men](https://pubmed.ncbi.nlm.nih.gov/16174713/) reported hormonal activity, including a testosterone rise. The [repeated-exposure experiment in women with hypothalamic amenorrhea](https://pubmed.ncbi.nlm.nih.gov/19820030/) found a fading LH response. They investigate different populations and outcomes; together they place the follow-up at the centre of my curiosity.

I began by being impressed that the signal could be stimulated. I now give equal attention to the conditions under which a response persists, weakens or fails to appear. That is a change in emphasis, and it leaves plenty of room for enthusiasm about a good experiment.

## An editorial project

Real TRT is the name of these pages, not a clinic or a treatment business. My subject here is published research; there is no prescribing, medicine sales, dispensing or arrangement of care here. Nothing on the site is medical advice.

The subject is deliberately specific: kisspeptin and the questions raised by its reproductive and sexual-desire research. This is no comprehensive account of testosterone treatment. A person deciding about care needs an assessment of their own circumstances, which a collection of essays cannot provide.

My favourite experiments make the original question less comfortable. The [participants whose kisspeptin response failed to appear](https://pubmed.ncbi.nlm.nih.gov/25226293/) expose a gap in any simple account of the healthy-men response: the disagreement asks for an explanation. The [sexual-desire trial](https://pubmed.ncbi.nlm.nih.gov/36735255/) opens another promising question with outcomes of its own.

My judgement can change when a better experiment arrives. For now, this subject seems worth the time precisely because its genuinely interesting findings leave consequential work to do.

---

At Real TRT I scrutinise published research on kisspeptin and testosterone; this is an editorial site rather than a treatment business, and none of it is medical advice.